News
10-28-2015, 06:10 AM
Cynosure, Inc. today announced that it has received a medical device license issued by Health Canada to market MonaLisa Touch® for the treatment of symptoms related to Genitourinary Syndrome of Menopause (GSM), including vaginal dryness, vaginal burning, vaginal itching, pain, dysuria and dyspareunia.
More... (http://www.news-medical.net/news/20151028/Cynosure-obtains-medical-device-license-from-Health-Canada-to-market-MonaLisa-Touch-for-treatment-of-GSM-symptoms.aspx)
More... (http://www.news-medical.net/news/20151028/Cynosure-obtains-medical-device-license-from-Health-Canada-to-market-MonaLisa-Touch-for-treatment-of-GSM-symptoms.aspx)